These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18684890)

  • 1. A role for the thromboxane receptor in L-NAME hypertension.
    Francois H; Makhanova N; Ruiz P; Ellison J; Mao L; Rockman HA; Coffman TM
    Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1096-102. PubMed ID: 18684890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for thromboxane receptors in angiotensin-II-induced hypertension.
    Francois H; Athirakul K; Mao L; Rockman H; Coffman TM
    Hypertension; 2004 Feb; 43(2):364-9. PubMed ID: 14718360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants on rat chromosome 8 exhibit profound effects on hypertension severity and survival during nitric oxide inhibition in spontaneously hypertensive rats.
    Schulz A; Schütten-Faber S; Schulte L; Unland J; Kossmehl P; Kreutz R
    Am J Hypertens; 2014 Mar; 27(3):294-8. PubMed ID: 24363279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP receptors regulate renal hemodynamics during angiotensin II slow pressor response.
    Kawada N; Dennehy K; Solis G; Modlinger P; Hamel R; Kawada JT; Aslam S; Moriyama T; Imai E; Welch WJ; Wilcox CS
    Am J Physiol Renal Physiol; 2004 Oct; 287(4):F753-9. PubMed ID: 15213069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
    Valentin JP; Bessac AM; Maffre M; John GW
    Eur J Pharmacol; 1996 Dec; 317(2-3):335-42. PubMed ID: 8997619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between nitric oxide and prostanoids in isolated perfused kidneys of the rat.
    Ziyyat A; Zhang BL; Benzoni D
    Br J Pharmacol; 1996 Sep; 119(2):388-92. PubMed ID: 8886425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist.
    Okamura M; Konishi Y; Nishimura M; Umetani N; Iwai J; Negoro N; Inoue T; Takeda T; Kanayama Y
    Blood Press Suppl; 1994; 5():75-8. PubMed ID: 7889207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
    Uhlenius N; Vuolteenaho O; Tikkanen I
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of chronic inhibition of nitric oxide synthesis and dietary salt in spontaneously hypertensive rats.
    Vaskonen T; Mervaala E; Krogerus L; Teräväinen TL; Laakso J; Karppanen H; Vapaatalo H
    Hypertens Res; 1997 Sep; 20(3):183-92. PubMed ID: 9328799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium sensitivity and sympathetic nervous system in hypertension induced by long-term nitric oxide blockade in rats.
    Yuasa S; Li X; Hitomi H; Hashimoto M; Fujioka H; Kiyomoto H; Uchida K; Shoji T; Takahashi N; Miki S; Miyatake A; Mizushige K; Matsuo H
    Clin Exp Pharmacol Physiol; 2000; 27(1-2):18-24. PubMed ID: 10696524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between nitric oxide and mineralocorticoids in the long-term control of blood pressure.
    Alvarez G; Osuna A; Wangensteen R; Vargas F
    Hypertension; 2000 Mar; 35(3):752-7. PubMed ID: 10720590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of COX-2 prevents hypertension and proteinuria associated with a decrease of 8-iso-PGF2alpha formation in L-NAME-treated rats.
    Tomida T; Numaguchi Y; Nishimoto Y; Tsuzuki M; Hayashi Y; Imai H; Matsui H; Okumura K
    J Hypertens; 2003 Mar; 21(3):601-9. PubMed ID: 12640255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
    Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
    Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic increased salt intake on nitric oxide synthesis inhibition-induced hypertension.
    Fernández-Rivas A; García-Estañ J; Vargas F
    J Hypertens; 1995 Jan; 13(1):123-8. PubMed ID: 7759842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis signal-regulating kinase-1 is involved in vascular endothelial and cardiac remodeling caused by nitric oxide deficiency.
    Yamashita T; Yamamoto E; Kataoka K; Nakamura T; Matsuba S; Tokutomi Y; Dong YF; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2007 Sep; 50(3):519-24. PubMed ID: 17646574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
    Koshikawa S; Nishikimi T; Inaba C; Akimoto K; Matsuoka H
    J Hypertens; 2008 Sep; 26(9):1837-48. PubMed ID: 18698220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.
    Pojoga LH; Yao TM; Opsasnick LA; Siddiqui WT; Reslan OM; Adler GK; Williams GH; Khalil RA
    J Pharmacol Exp Ther; 2015 Oct; 355(1):32-47. PubMed ID: 26183312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism.
    Suo M; Kalliovalkama J; Pörsti I; Jolma P; Tolvanen JP; Vuolteenaho O; Ruskoaho H
    J Cardiovasc Pharmacol; 2002 Sep; 40(3):478-86. PubMed ID: 12198334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.